Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN
Clinical trial NCT03203369 · TERMINATED
Trial details
- NCT number
- NCT03203369
- Sponsor
- Cellectis S.A.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-28
- Primary completion
- 2019-06-27
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.